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Cyclodipeptide synthases (CDPSs) use as substrates two amino acids activated as
aminoacyl-tRNAs to synthesize cyclodipeptides in secondary metabolites biosynthetic
pathways. Since the first description of a CDPS in 2002, the number of putative CDPSs
in databases has increased exponentially, reaching around 800 in June 2017. They
are likely to be involved in numerous biosynthetic pathways but the diversity of their
products is still under-explored. Here, we describe the activity of 32 new CDPSs, bringing
the number of experimentally characterized CDPSs to about 100. We detect 16 new
cyclodipeptides, one of which containing an arginine which has never been observed
previously. This brings to 75 the number of cyclodipeptides formed by CDPSs out of the
possible 210 natural ones. We also identify several consensus sequences related to the
synthesis of a specific cyclodipeptide, improving the predictive model of CDPS specificity.
The improved prediction method enables to propose the main product synthesized
for about 80% of the CDPS sequences available in databases and opens the way
for the deciphering of CDPS-dependent pathways. Analysis of phylum distribution and
predicted activity for all CDPSs identified in databases shows that the experimentally
characterized set is representative of the whole family. Our work also demonstrates that
some cyclodipeptides, precursors of diketopiperazines with interesting pharmacological
properties and previously described as being synthesized by fungal non-ribosomal
peptide synthetases, can also be produced by CDPSs in bacteria.
Keywords: secondary metabolites, biosynthetic pathways, cyclodipeptide synthase, tRNA-dependent enzymes,
diketopiperazine, activity prediction, cyclodipeptide MS/MS
INTRODUCTION
Cyclodipeptide synthases (CDPSs) are a novel family of enzymes that use aminoacyl-tRNAs
(aa-tRNAs) as substrates for the biosynthesis of various cyclodipeptides (Gondry et al., 2009;
Moutiez et al., 2017), precursors of diketopiperazines (DKPs), a large class of natural products
with noteworthy biological activities (Borthwick, 2012). Since the first description of a CDPS
enzyme in 2002 (Lautru et al., 2002), 66 members have been characterized for their cyclodipeptide-
synthesizing activities (Gondry et al., 2009; Seguin et al., 2011; Giessen et al., 2013a,b; Alqahtani
et al., 2015; Jacques et al., 2015; James et al., 2016; Brockmeyer and Li, 2017; Patteson et al., 2017).
Gondry et al. Newly Characterized Cyclodipeptide Synthases
Most CDPSs are promiscuous enzymes, synthesizing one
main cyclodipeptide and one or several minor cyclodipeptides.
Globally, they synthesize about 55 different cyclodipeptides made
up of 17 proteinogenic amino acids.
We recently showed that CDPSs divide into two
phylogenetically distinct subfamilies named NYH and
XYP, according to the identity of a trio of essential residues
(Jacques et al., 2015). The NYH enzymes have been extensively
characterized and the crystal structures of three of them,
AlbC from Streptomyces noursei, Rv2275 from Mycobacterium
tuberculosis and YvmC from Bacillus licheniformis, are available
(Vetting et al., 2010; Bonnefond et al., 2011; Sauguet et al.,
2011; Moutiez et al., 2014a). These CDPSs adopt a common
architecture with a monomer containing a Rossmann-fold
domain. The catalytic mechanism used by these three CDPSs has
been investigated (Vetting et al., 2010; Bonnefond et al., 2011)
and fully elucidated for AlbC (Sauguet et al., 2011; Moutiez et al.,
2014a). The AlbC catalytic cycle begins with the binding of the
first aa-tRNA, with its aminoacyl moiety accommodated in a
surface-accessible pocket P1 and transferred onto a conserved
serine residue to form an aminoacyl-enzyme intermediate.
The second aa-tRNA interacts with this intermediate so that
its aminoacyl moiety, accommodated in a wide cavity P2, is
transferred to the aminoacyl-enzyme to form a dipeptidyl-
enzyme intermediate. Finally, the dipeptidyl moiety undergoes
an intramolecular cyclization leading to the final cyclodipeptide.
We previously proposed an approach to predict the main
cyclodipeptide produced by yet-to-be characterized CDPSs
(Jacques et al., 2015). Briefly, structural studies on the CDPS
AlbC led to the identification of the two pockets P1 and P2
and showed that these pockets are bordered by eight and seven
residues, respectively (Sauguet et al., 2011; Moutiez et al., 2014a).
Assuming that the positions of residues lining P1 and P2 are
conserved in all CDPSs and that their nature is related to
the recognized aminoacyl moiety, specificity sequence motifs
were defined for P1 and P2 for all putative new CDPSs. These
motifs were used in combination with phylogenetic distribution
to predict the main product of yet-to-be characterized CDPSs
and to classify them into different specificity-based groups,
according to the predicted product. For CDPSs producing the
same main cyclodipeptide, the residues lining P1 and P2 appear
well conserved within a subfamily, allowing the definition of
consensus motifs specific to various specificity-based groups of
CDPSs (Jacques et al., 2015). Six groups containing at least five
characterized members were shown to be predictable with a good
level of confidence (Jacques et al., 2015). For four of these groups,
consensus motifs of P1 and P2 pockets have been identified and
correspond to the synthesis of cWW, cLL, cCC, or cAE as the
main cyclodipeptide. For the two others, the consensus motif
is known for only one of the two pockets and correspond to
the synthesis of a glutamyl- or alanyl-containing cyclodipeptide,
respectively named cXE and cAX (X means that the nature
of the other amino acid incorporated differs according to the
CDPS considered). Few other groups could be postulated but
not formally established as they contained only one to three
characterized enzymes. On the 257 characterized and putative
CDPSs identified in the National Center for Biotechnology
Information (NCBI) database in 2015, 42% belonged to a well-
defined group, 40% to other putative groups not formally defined
and 18% had unpredictable activities. This last group is of
particular interest since CDPSs with unpredictable activities are
likely to produce new cyclodipeptides (Jacques et al., 2015).
Here, we describe 32 new active CDPSs, most of them
chosen among the putative enzymes with unpredictable activities.
This allows us to identify new cyclodipeptides produced by
CDPSs and to define new consensus motifs, thus improving
the predictive model of CDPS activity. We updated the list of
putative CDPSs found in the NCBI database and retrieved about
500 new sequences (June 2017), which were analyzed with the
improved predictive model to propose the main cyclodipeptide
they produce. We also consider the phylum distribution of the
family and potential relationship with CDPS specificities. Finally,
we characterized several CDPSs synthesizing cyclodipeptides that
were also previously shown to be synthesized by non-ribosomal
peptide synthetases (NRPSs).
MATERIALS AND METHODS
Bioinformatics Analyses
The BLAST tools and resources of NCBI databases have been
routinely used. Sequences truncated at the N-terminus were
corrected when possible. For each of these proteins, we examined
the 5′ surrounding DNA sequence of the annotated gene to
identify an alternative start codon located upstream, leading
to an extended amino acid sequence that contains all catalytic
residues and matches correctly with the N-terminal part of the
previously characterized CDPSs. Sequences truncated at the C-
terminus or lacking the catalytic serine were removed. Only
one sequence was kept when several sequences exhibiting more
than 98% sequence identity were found. Multiple sequence
alignments were done using Muscle, integrated into Seaview
(Gouy et al., 2010). Alignments were further manually curated
for accurate alignment of catalytic residues. HHPred analyses
were performed for sequences with catalytic residues variations,
making not obvious the alignment of catalytic residues (Alva
et al., 2016). Residues lining P1 and P2 were determined from
these alignments, using data obtained with AlbC (Moutiez
et al., 2014a). Eight residues line P1 (Residues 33-35-65-67-
119-185-186-200, AlbC numbering) while seven residues line P2
(Residues 152-155-156-159-204-206-207, AlbC numbering). The
phylogenetic trees were calculated using the PhyML program
(v 3.1) based on maximum-likehood method (LG substitution
model and NNI tree searching operation) (Lefort et al., 2017).
The iTOL suite was used to generate graphical representation of
phylogenetic trees (Letunic and Bork, 2016). Sequence consensus
motifs were represented as logos, obtained at the WebLogo
website (http://weblogo.berkeley.edu/; Schneider and Stephens,
1990; Crooks et al., 2004).
CDPS Genes
Synthetic genes encoding CDPSs 62-103 and optimized for
expression in E. coli were obtained from GeneArt. They were
designed on the same basis as in Jacques et al. (2015), i.e.,
they were designed to have an NcoI restriction site (CCATGG)
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containing the ATG start codon and a BglII restriction site
located downstream from the last codon of the coding sequence.
If the residue following the initiating methionine could not be
encoded by a GXX codon, an alanine-encoding codon (GCA)
was introduced after the start codon to complete the NcoI motif.
The synthetic genes were provided in GeneArt specific cloning
vectors. Their sequences are given in Supplemental Data Set 1.
CDPS coding sequences were then inserted between theNcoI and
BglII restriction sites of pIJ196 for protein expression in E. coli
(Jacques et al., 2015). All recombinant plasmids were prepared
using DH5α bacteria and verified by DNA sequencing of the
promoter and CDPS-encoding regions (Eurofins-MWG).
Expression of CDPSs and Sample
Preparation
Each recombinant putative CDPS was expressed in E. coli
BL21AI-pREP4 in medium throughput format from the
corresponding pIJ196-derived plasmid (Jacques et al., 2015). An
expression trial was performed in E. coli M15-pREP4 for CDPSs
found inactive or poorly active in BL21AI-pREP4. Bacteria were
cultured in 10ml 24-well plates with round-bottomed wells
(Whatman/GE Healthcare) containing 2ml of the appropriate
growth medium, covered with a hydrophobic porous film
(VWR), and shaken at 200 rpm. Starter cultures wereM9-derived
minimum medium supplemented with trace elements and
vitamins (Gondry et al., 2009), 200µg/ml ampicillin, 25µg/ml
kanamycin and 0.5% glucose. They were inoculated with several
colonies from competent bacteria freshly transformed with
plasmids encoding CDPSs. After an overnight incubation at
37◦C, the starter culture was used to inoculate (1/50) the same
M9-derived minimum medium except that glucose was replaced
by a combination of 0.5% glycerol, 0.05% glucose, and 0.02%
lactose for BL21AI-pREP4 bacteria (Studier, 2005) or by 0.5%
glycerol for M15-pREP4 bacteria. M15-pREP4 bacteria were
grown at 37◦C until the OD600 reached 0.6, and expression of
the putative CDPS was induced by the addition of isopropyl-
β-D-thiogalactopyranoside (IPTG, 2mM final concentration).
Cultivation was continued for 24 h at 20◦C. BL21AI-pREP4
bacteria were grown in an auto-induced medium (Studier,
2005) and thus did not need the addition of IPTG for CDPS
expression. After inoculation of the expression cultures, BL21AI-
pREP4 bacteria were grown at 37◦C for 3.5 h, and transferred
to 20◦C for 20.5 h. At the end of cultivation, cells were
pelleted by centrifugation of the plates. The supernatants were
collected, acidified (2% TFA final concentration) and frozen
at−20◦C.
Cyclodipeptide Identification
Cyclodipeptides were detected by LC-MS/MS analyses on an
Agilent 1100 HPLC coupled via a split system to an Esquire
HCT ion trap mass spectrometer (Bruker Daltonik GmbH) set
in positive mode. Samples were loaded onto an Altantis dC18
column (4.6× 150mm, 3µm, 100 Å, Waters) or on a Hypercarb
column (4.6 × 150mm, 5µm, 250 Å, ThermoScientific),
developed over 50min with the linear gradient 0–50% (v/v)
(solvent A: 0.1% (v/v) formic acid in H2O, solvent B: 0.1% (v/v)
formic acid in acetonitrile/H2O (90/10), flow rate, 0.6 ml/min).
Analysis on dC18 column proved to be efficient to detect most
of the cyclodipeptides, except the most polar ones such as cGG,
cGN (Jacques et al., 2015). Hypercarb column efficiently separates
hydrophilic cyclodipeptides but is not suitable for the separation
of aromatic-containing ones. Positive electrospray ionization and
mass analysis were optimized for the detection of compounds in
the range of natural cyclodipeptides. For MS/MS, an isolation
width of 1.0 m/z was set for isolating the parent ion, and a
fragmentation energy ramp was used for optimizing the MS/MS
fragmentation process. All data were acquired and processed
using software from the manufacturer (Bruker Daltonik GmbH).
Cyclodipeptides were detected and identified from both
the m/z value of their [M+H]+ species (MS) and their
daughter ion spectra (MS/MS), as a result of their common
fragmentation patterns. The identification of the detected
cyclodipeptides was done from data gathered in Table S1
and Supplemental Data Set 2. Table S1 has been established
from a compilation of our experimental results on authentic
standards (bought or chemically synthesized in the lab, see
Supplemental Data Set 2), completed by relevant literature data
(Papayannopoulos, 1995; Chen et al., 2004; Stark and Hofmann,
2005; Xing et al., 2008; Guo et al., 2009; Jacques et al., 2015).
The identity of cPR, also known as verpacamide A, was
confirmed by comparison with an authentic standard (Vergne
et al., 2006), which was also used to obtain a calibration curve
relating mass concentration and peak area at 214 nm.
Cyclodipeptides were quantified on the basis of their peak area
at 214 nm, possibly converted inmg/L of culture using calibration
curves performed with standards, when commercially available
(see Supplemental Data Set 2).
RESULTS
Newly Characterized CDPSs and the
Cyclodipeptides They Produce
We investigated the production of cyclodipeptides
of 42 selected sequences (designated CDPSs 62-103)
(Supplemental Data Set 1). Thirty sequences were selected
from the 257-sequence set published in 2015 (Jacques et al.,
2015) and 12 from a new set obtained from analyses performed
in March 2016. Thirty-six of the 42 selected enzymes cannot
be associated with any obvious predictable activity using the
model proposed by Jacques et al. Nine are XYP members and
27 are NYH members. The discrepancy between the number of
XYP and NYH CDPSs selected is directly related to the much
smaller number of XYP sequences available in databases. The
six remaining proteins were chosen to assess the predictive
value of several putative specificity-groups. Four are NYH
(CDPSs 94-97) and two are XYP proteins (CDPSs 85-86), which
may belong to putative specificity-groups that synthesize cYY
and cLI/cLL, respectively (Jacques et al., 2015). Among the
27 unpredictable NYH members selected, ten (CDPSs 62-66,
68-71, 103) had been put into the putative specificity-group
containing AlbC by Jacques et al., suggesting that the main
cyclodipeptide they synthesize is a phenylalanyl-containing
cyclodipeptide, named cFX (with X differing depending on the
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CDPS considered) (Jacques et al., 2015). However, this grouping
has been brought into question by the recent characterization of
one member, NozA, as a cWW-synthesizing enzyme, whereas
it was grouped with AlbC (Alqahtani et al., 2015; James et al.,
2016). Characterization of this subset thus aimed to identify
the compounds formed by members of this group, formerly
thought to be homogenous. We cloned each of the genes in
a vector allowing their expression in E. coli. We used the
medium-throughput method previously described to recover the
cyclodipeptides synthesized by CDPSs in culture supernatants
(Jacques et al., 2015). These supernatants were then analyzed by
LC-MS/MS to detect and identify the cyclodipeptides produced.
Thirty-two of the 42 selected CDPSs had cyclodipeptide-
synthesizing activity under the conditions tested (Table 1;
Supplemental Data Set 3). There is no obvious explanation for
the absence of activity of the others (see the end of the 4th
paragraph of the Results section). Altogether, the 32 active CDPSs
produced 52 cyclodipeptides, among which 16 have not been
previously observed as CDPS products (Figure 1). In addition,
five cyclodipeptides previously detected only at trace levels
(Jacques et al., 2015) were now obtained in significant amounts
(Figure 1). We observed for the first time, the incorporation
of a basic residue into a CDPS product, as NYH CDPS 83
synthesizes cPR (Table 1). This brings the number of amino
acids now incorporated into cyclodipeptides to 18 of the 20
proteinogenic ones (except for D and K), and the total number
of cyclodipeptides synthesized to date by CDPSs to 75 of the
210 natural cyclodipeptides made up of proteinogenic amino
acids.
The newly characterized NYHCDPSs synthesize 22 additional
cyclodipeptides, completing the set of products obtained with
the former characterized NYH group, bringing this set to
52 cyclodipeptides (Figure S1A). The NYH enzymes now
incorporate 17 of the 20 proteinogenic amino acids, except for
H, D, and K. The newly characterized XYP CDPSs produced
nine additional products. This new set of XYP enzymes
produced a total of 51 different cyclodipeptides, in which are
incorporated 17 of the 20 proteinogenic amino acids, differing
from NYH members by the exclusion of R instead of H
(Figure S1B).
The Contribution of the Newly
Characterized CDPSs to the Determination
of Specificity Groups
We examined the main cyclodipeptide synthesized by each of the
newly characterized CDPSs, together with the sequence motifs
of the binding pockets and the phylogenetic proximity of the
considered enzymes (Table 2).
CDPSs that synthesize the same main product but belong
to either the XYP or NYH subfamily (e.g., NYH CDPSs 94-97
and XYP CDPS 101, which synthesize cYY), have pockets with
different sequence motifs. This feature had already been observed
for cLL-synthesizing enzymes (Jacques et al., 2015) and appears
to be the general case.
A few sets of CDPSs that synthesize the same main product
share common features. The first set corresponds to NYH CDPSs
94-97, which synthesize cYY. The sequence motifs for P1 are
highly conserved, with the only variable position occurring on
the third residue (position 65, AlbC numbering), which is either
valine or isoleucine. Four of the seven residues of pocket P2 are
strictly conserved and a fifth residue is either phenylalanine or
tyrosine. The combination of these two motifs is specific for this
set of CDPSs. Other NYH CDPSs that bind a tyrosinyl in the
second pocket, but synthesize cyclodipeptides other than cYY,
exhibit different P2 motifs (e.g., CDPSs 66, 67, 69, and 71). The
second set includes XYP CDPSs 85 and 86, which synthesize cLI
or cLL as the main products and have highly similar P1 and P2
sequences motifs.
Nine of the 10 CDPSs previously grouped with AlbC
were active (Table 1). Experimentally, they divided into two
groups, synthesizing as the main product either a phenylalanine-
containing cyclodipeptide (CDPSs 62, 66, 103) like AlbC
or cWW (CDPSs 63, 64, 68-71) like NozA (James et al.,
2016). As we previously demonstrated that phenylalanyl is
accommodated in P1 for AlbC (Moutiez et al., 2014b), we
can assume that CDPSs, that belong to the group of AlbC,
also accommodate phenylalanyl in P1 whereas CDPSs of the
second group accommodate tryptophanyl. Sequence motifs of P1
must have sufficient differences to allow the accommodation of
one or the other residue. Examination of P1 motifs (Table 2)
showed that CDPSs accommodating tryptophanyl always have
the pair VA or IA at positions 3 and 4 of P1, whereas CDPSs
that accommodate phenylalanyl have different combinations of
amino acids. However, one of the enzymes that preferentially
accommodates phenylalanyl has the VA pair (CDPS 66), showing
that discrimination between phenylalanyl and tryptophanyl by
P1 is complex and probably involves other not yet identified
specific residues. Both groups are nevertheless on separate
branches of the phylogenetic tree (Table 2 and Figure 2).
CDPSs 73-75 mainly synthesize a tryptophanyl-containing
cyclodipeptide but are not located in the same region of the
phylogenetic tree as the tryptophanyl-accommodating CDPSs
similar to NozA, described above. The only significant difference
between these two CDPS sets occurs at the fourth residues of
P1 (position 119, AlbC numbering), which is proline in the set
containing CDPSs 73-75 and alanine in the other (CDPSs 63, 64,
68-71). Analysis of the amino acids lining the pocket P2 in these
CDPSs did not reveal consensus motifs related to the recognition
of a particular aminoacyl.
The last set contains CDPSs that synthesize a prolyl-
containing cyclodipeptide as the main product (CDPSs 82, 83,
98, and 100). These enzymes are not closely related from a
phylogenetic point of view (Figure 2) and their main product
differs. Their P2 sequence motifs do not contain any common
amino acids, but their P1 sequence motifs show some common
features, suggesting that prolyl is bound by P1. However, other
specificity determinants are likely involved in the recognition of
prolyl because CDPSs with similar P1 motifs exhibit different
specificities (e.g., CDPS 84, which mainly synthesizes cFI or
CDPS 77, which synthesizes leucyl-containing cyclodipeptides).
Studies of larger sets of CDPSs with the same specificity should
provide further keys to connect essential sequence elements with
the observed specificity.
Frontiers in Microbiology | www.frontiersin.org 4 February 2018 | Volume 9 | Article 46
Gondry et al. Newly Characterized Cyclodipeptide Synthases
TABLE 1 | Cyclodipeptides produced by the newly characterized CDPSs.
CDPS Species CDPS
subfamily
In vivo activity (BL21 AI-pREP4)a UV214 nm area of
main compound
Quantity in mg/L
cultureb
62 Nocardiopsis potens NYH cFM (30%), cFF (30%), cFA (19%), cFY (8,4%), cFL (7%), cYA,
cFW, cMM, FV, cLM, cLY
2,650 cFM 8.8, cFF 7
63 Streptomyces lavendulae NYH cWW (62%), cWP (15,8%), cWA (9,8%), cWL (6,2%), cWS (2%),
cWQ, cWE, cWF,cWC, cWG, cWI, cWN
14,802 cWW 20
64 Streptomyces purpureus NYH cWW (100%) 9,573 cWW 12.7
65 Nocardiopsis xinjiangensis NYH –
66 Actinomadura oligospora NYH cFY (94,3%), cYY (5,7%) 2,729 cFY 6.5
67 Streptomyces catenulae NYH cFY (99,9%) 1,969 cFY 5.1
68 Streptomyces sp. NRRL F-5053 NYH cLW (97%), cLL , cFW, cFL 11,431 cLW 13.6
69 Streptomyces rimosus NYH cWY (98%), cWW (2%) 11,709 cWY 7
70 Streptomyces sp. NRRL B-24484 NYH cWW (73,2%), cWL (16,5%), cWS (8,9%), cWQ, cWF, cWN,
cWA,cWP, cWE, cWG
18,457 cWW 39
71 Strepto. roseochromogenes
subsp. Oscitans DS 12.976
NYH cWY (98%), cWA (2%), cWS 4,667 cWY 3
72 Streptomyces sp. AW19M42 NYH –
73 Streptomyces aureocirculatus NYH cWA (60%), cWP (40%) 138
74 Streptomyces sp. NRRL S-1868 NYH cWP (99,5%), cWA, cWS 15,655
75 Streptomyces sp. NRRL F-5123 NYH cWP (99,5%), cWF, cWG 7,616
76 Streptacidiphilus albus NYH –
77 Streptomyces scabrisporus NYH cLV (56,2%), cLT (5,9%), cLL (18%), cLI (18,3%), cLA 1,715 cLV 5.5, cLL 6, cLI
6
78 Kibdelosporangium aridum NYH cFG (100%) 51 cFG < 0.1
79 Kibdelosporangium aridum NYH –
80 Streptomyces natalensis NYH –
81 Streptomyces roseoverticilatus NYH –
82 Streptomyces varsoviensis NYH cPL (65,8%), cPA (20%), cPV (7,6%), cPF, cPM, cLL, cLA, cPI,
cAA
5,945 cLP 2
83 Lysobacter antibioticus NYH cPR (100%) 140 cPR 4
84 Allokutzneria albata NYH cFI (100%), cLI, cMI 54 cFL 0.2
85 Actineokineospora sp. EG49 XYP cLI (65,7%), cMI (9,1%), cLL (5,4%), cML (3,3%), cLV (4,9%), cLP
(4,6%), cLA (3,3%), cLC, cMV, cMP, cMA, cIA
4,220 cLIc 46, cLL 3.7
86 Hahella ganghwensis XYP cLL (50,6%), cLI (17,9%), cLP (10,6%), cLA (9,1%), cLM (7%),
cLV (4,2%), cLC, cMI, cLT, cMA, cMP, cLY, cMV
926 cLL 10, cLIc 3.5
87 Legionella lansingensis XYP cGE (100%) 3,121 cGE 14
88 Geminicoccus roseus XYP –
89 Algicola sagamiensis XYP cAP (97%), cAA (3%) 3,454
90 Parcubacteria bacterium
RAAC4_OD1_1
XYP cHP (44%), cHE (56%) 688 cHP 0.4
91 Methylovulum miyakonense XYP cFF (51,5%), cFY (36,1%), cFL (8,2%), cFM (3,5%), cYM 2,786 cFF 6.5, cFY 4,
cFL 1.4
92 Aminiphilus circumscriptus XYP –
93 Fusarium fujikuroi IMI 58289 XYP –
94 Streptomyces katrae NYH cYY (71,3%), cYF (14,9%), cYA (10,7%), cYM (2%), cFF, cFA, cYL,
cYS
12,312 cYY 29.3, cYF 6.6,
cYA 5.5
95 Streptacidiphilus melanogenes NYH cYY (59,6%), cYA (22,2%), cYF (16,3%), cYM, cFF, cFA, cYL , cYS 11,078 cYY 26.4, cYA
12.3, cYF 8
96 Streptomyces sp. PCS3-D2 NYH cYY (57,7%), cYA (22,2%), cYF (17,5%), cYM, cFF, cFA, cYL 10,901 cYY 26, cYA 12.5,
cYF 8.6
97 Streptomyces peruviensis NYH cYY (58,4%), cYA (28,8%), cYF (11,2%), cYM, cFF, cFA, cYL 10,095 cYY 24, cYA 14.8,
cYF 5
98 Vibrio sagamiensis NYH cPM (95,4%), cMA (4,6%), cPA 6,265 cPM 2.6
99 Lyngbya confervoides XYP –
(Continued)
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TABLE 1 | Continued
CDPS Species CDPS
subfamily
In vivo activity (BL21 AI-pREP4)a UV214 nm area of
main compound
Quantity in mg/L
cultureb
100 Nocardia concava NYH cPP (100%) 1,871
101 Thalassomonas viridans XYP cYY (98%), cYM (2%) 3,406 cYY 8.1, cYM 0.2
102 Algicola sagamiensis NYH cCG (72,8%), cCC (27,2%) 596
103 Streptomyces sp. HPH0547 NYH cFL (91%), cFM (7%), cFF, cYL, cLM 16,190 cFL 21.3, cFM 1.6
aCyclodipeptides produced by BL21 AI-pREP4 expressing the recombinant CDPS; cyclodipeptides are ranked according to the peak area on UV chromatograms recorded at 214 nm
(see also Supplemental Data Set 3). Percentages in brackets indicate the proportion of each cyclodipeptides and were calculated from these UV peak areas. The most abundant
cyclodipeptide produced is in bold. Cyclodipeptides representing less than 2% are in italic.
bQuantities of cyclodipeptide produced are given in gray when standard are available for establishing of calibration curves (see also Supplemental Data Set 2).
ccLI quantities were estimated using the calibration curve for cLL.
FIGURE 1 | Current diversity of the cyclodipeptides produced by the CDPS
family. The amino acids forming the cyclodipeptide ring are indicated in the
one-letter code at the top and right. Previously identified cyclodipeptides are in
blue, cyclodipeptides identified with the present set of CDPSs are in orange.
Light colors indicate cyclodipeptides detected in low amounts (UV peak area
at 214 nm less than 200). The distribution of cyclodipeptides according to
NYH or XYP subfamilies is shown in Figure S1.
An Enlarged Set of Predictable Activities
We extended our analysis to all CDPSs biochemically
characterized to date. This set now consists of 98 active
CDPSs (Gondry et al., 2009; Seguin et al., 2011; Giessen et al.,
2013a,b; Alqahtani et al., 2015; Jacques et al., 2015; James et al.,
2016; Brockmeyer and Li, 2017; Patteson et al., 2017). The
products and P1 and P2 motifs of all the enzymes previously
characterized are shown in blue in Supplemental Data Set 4.
CDPSs are grouped according to their subfamily, NYH or
XYP, the main cyclodipeptide formed, and their phylogenetic
proximity. Several sets now contain a sufficient number of
members to implement the predictive method proposed by
Jacques et al. (2015).
The clearest new predictable activity concerns the synthesis
of cYY by NYH CDPSs related to Rv2275 (Gondry et al.,
2009; Vetting et al., 2010). This group now encompasses six
characterized enzymes, four of which (CDPSs 94-97) are from
this study. These enzymes all possess similar motifs for P1 and
P2, making it possible to define the consensus motifs reported in
Table 3.
The other predictable groups are restricted to the prediction
of the aminoacyl recognized by the first pocket P1, as key
determinants for the specificity of P2 are not yet clear.
Two NYH groups are predicted to mainly synthesize a cWX.
The first group (Table 3, group cW1X) contains the CDPSs 73-
75, characterized in this study, together with the entire previously
identified group that mainly synthesizes cWW (Jacques et al.,
2015). The other group (cW2X) includes CDPSs 63, 64, 68-71,
and NozA (James et al., 2016).
NYH CDPS 102 mainly synthesizes cCG and can be grouped
with the group that mainly synthesize cCC, defining a cCX-
synthesizing group (with X differing according to the CDPS).
Another group mainly synthesizes a cFX compound, as AlbC;
it contains CDPSs 62, 66, 67, four previously characterized
members (Gondry et al., 2009; Giessen et al., 2013b; Li et al.,
2014; Jacques et al., 2015) and a recently identified member that
produces mainly cFY (Brockmeyer and Li, 2017).
As noted above, predicting the synthesis of a cPX
compound is challenging, as the characterized members are
not phylogenetically grouped. We observed that the previously
characterized CDPS 10 (Jacques et al., 2015), which mainly
synthesizes mainly cPM, also has a sequence motif for P1
homologous to that of cPX-synthesizing CDPSs of this study.
However, the prediction is uncertain, except for new CDPSs
phylogenetically close to those already characterized.
Among the new XYP CDPSs, CDPS 87 exhibits a P2 sequence
motif similar to that of the subgroup that synthesizes cXE
cyclodipeptides (Jacques et al., 2015). Before our study, no clues
were available concerning the specificity of the P1 pocket. We
observed that CDPS 87 specifically produces cGE. This enlarges
the number of XYP CDPSs considered to predict the binding
of glutamyl in P2 and slightly modifies the previously proposed
consensus sequence (Jacques et al., 2015).
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TABLE 2 | Sequence motifs of the pockets P1 and P2 of characterized CDPSs,
colored according to the aminoacyl mainly accommodated* (inferred from
sequence alignments and proximity with characterized CDPSs or enzymes
synthesizing homo-cyclodipeptides).
Pocket P1 Pocket P2
CDPS Amino acyl
mainly
accommodated
Sequence
motifs
Amino acyl
mainly
accommodated
Sequence
motifs
NYH
94 Y VGITMLFN Y LRFDQLP
95 Y VGVTMLFN Y LAYSQLP
96 Y VGITMLFN Y LAFSQLP
97 Y VGVTMLFN Y LSFEQLP
67 F VGITMFFV Y MHFGVTP
66 F LGVAIFLC Y HFVGKLP
62 F LGVVLFFT F/M QDFDKMP
103 F LGLVLFLT L QALEKMP
68 W LGVALFLS L MSFGMAQ
63 W LGVALFFA W MLHGVMP
70 W LGVALFFA W MGFAEPL
64 W LGVALFFH W MQFKTLA
69 W LGIALFFS Y MLHGLTP
71 W LGVALFFS Y MTFPQIP
73 W LGIPLFFV P/A VRARAGF
74 W LGIPLFFV P ARAVMVP
75 W LGVPLLLA P ASVGKID
100 P CGHPWLLY P TDVHRIP
82 P LGFPWFMF L LKAGQFE
83 P VGLPWFFF R ATAGRIS
98 P LGLPWLFF M NQCNSFR
77 L LGFPWLVF V/L/I TGARRMD
78 F/G ? LGLAWIGC F/G ? VAYHRLA
84 F/I ? LGLPWFLF F/I ? IRVTRSP
102 C VGYPSIFF G/C SAIKDPT
XYP
85 L/I ? FGLGCVFM L/I ? FRYRGFS
86 L/I ? FGLGCIFF L/I ? FSYRGFG
87 G LFVAWIVI E NTYRKLT
89 A/P ? FAYVHAVN A/P ? FFYRGID
90 H GAYAWELY P/E FEWKYTR
91 F FGLAWSLL F/Y LNYSTYA
101 Y FPLCWISE Y LKLRREE
* Orange: Y, blue: F, green: W, yellow: P, violet: L. When accommodation in P1 or P2
could not be deduced from existing data, amino acyl accommodated are indicated in
both pockets and signaled by a question mark. Groups of CDPSs phylogenetically close
are framed. NYH CDPSs previously grouped in the same specificity group than AlbC are
labeled in blue.
Overview of the Updated Family of CDPSs
(June 2017)
A new search of the NCBI database in June 2017 retrieved
765 putative CDPSs after curating the initial set of hits. We
constructed a phylogenetic tree with 568 CDPSs representative
of the entire set: only one enzyme sequence was retained for
CDPS sequences sharing more than 98% identical residues
(Figure 2 and Supplemental Data Sets 5, 6). All putative CDPSs
fall into the two previously identified subfamilies XYP and
NYH. Previously characterized CDPS 17 (Jacques et al., 2015),
suspected to be a representative of a third family (SYQ), now
clearly appears to be a member of the XYP subfamily. NYH
CDPSs form a larger group than their XYP homologs (507 vs.
258), but this persistent trend may be biased by the choice
of genome sequencing projects. Experimentally characterized
CDPSs are evenly distributed on the phylogenetic tree.
CDPSs close in the phylogenetic tree and with patterns of P1
or/and P2 similar to those of characterized CDPSs were grouped
together (Supplemental Data Set 4). In addition to the formally
established specificity groups (This study; Jacques et al., 2015), we
also considered five groups likely to synthesize cLI/cLL, cLE, cGE,
cAA, and cGG as their main products. The number of CDPSs
experimentally characterized for these groups, was between one
and four. Table 3 shows the sequence motifs determined for P1
and P2 from characterized enzymes for all defined specificity
groups. These groups appear in color in Figure 2 and their
distribution by predicted activity is shown in Figure 3. Although
the number of putative CDPSs has tripled since the last update
(September 2014), the number of CDPSs with unpredictable
activity is still approximately 18%. Sixty-six percent of the CDPSs
are predicted to mainly synthesize one of the 10 cyclodipeptides
for which the two amino acids can be predicted, i.e., cYY, cLL,
cCC, and cWW for NYH CDPSs and cAE, cLI/cLL, cAA, cLE,
cGG, and cGE for XYP CDPSs. Cyclodipeptides for which only
one amino acid can be predicted (i.e., cWX, cFX, or cPX)
are much more diverse (at least more than 12 different main
products according to our experimental results) and are the
main product of a restricted number of enzymes (11%). The
number of XYP enzymes is higher than NYH enzymes (94 vs.
68) if CDPSs with unpredictable activity are considered (see
Supplemental Data Set 4). Altogether, approximately 91% of the
activity of NYH CDPSs can be predicted using their pocket
sequence residues, whereas this figure falls to 73% for XYP
CDPSs.Most of the CDPSs predicted to synthesize the samemain
cyclodipeptide, are on a same branch of the phylogenetic tree and
form a distinct phylogenetic group.
The enzymes that were inactive under our experimental
conditions fell into one main group in each subfamily. Most of
the inactive enzymes for NYH CDPSs are clustered on the same
branch and belong to actinobacteria. The observed inactivity
may be due to errors in determining the start codon of the
CDPS genes. New NCBI entries are now available for some
of the enzymes studied and propose alternative start codons.
Many inactive enzymes of the XYP CDPSs belong to fungi,
cyanobacteria, or metagenomic species. The observed inactivity
may be due to the set of E. coli tRNAs being unsuitable for
a productive interaction with these enzymes, in addition to
potential errors in determining the start codons.
Phylum Distribution and Diversity of CDPSs
We examined the distribution of CDPSs in terms of the
organisms in which they are present (Figure 4). Experimentally
characterized CDPSs are representative of the whole set
Frontiers in Microbiology | www.frontiersin.org 7 February 2018 | Volume 9 | Article 46
Gondry et al. Newly Characterized Cyclodipeptide Synthases
FIGURE 2 | Phylogenetic tree of known and putative CDPSs (June 2017) (see also Supplemental Data Set 6 for a better resolution and aLRT values). The CDPSs
experimentally characterized prior to this study are labeled with blue dots and CDPS characterized within this study with pink dots (dark for active ones, light for
inactive ones). Branches corresponding to NYH CDPSs are black; those corresponding to XYP ones are gray. Labels of groups with predicted activity are colored
respectively in green (cLL), blue (cCC), light pink (cWW), orange (cPX), dark pink (cW1X), gray (cW2X), red (cFX), violet (cYY) for NYH CDPSs, and light blue (cAE),
brown (cLE), dark blue (cGE), yellow (cAA), light green (cGG), and fushia (cLI/cLL) for XYP CDPSs. The arrow indicates the CDPS 17, previously suspected to belong
to a third CDPS subfamily (SYQ). See also Supplemental Data Set 5 for the sequence alignment of the whole set of CDPSs.
(Figures 4A,B). Putative CDPSs appear in all domains of
life. For the first time we retrieved a sequence annotated as
originating from a metagenomic archaeon (AQS34941), that
possesses all characteristics of a XYP CDPS. It has the greatest
similarity with CDPS sequences from metagenomes, for which
the specificity is unknown. The number of putative eukaryotic
CDPSs has significantly increased (by a factor of approximately
two relative to the set published in 2015). Eukaryotic CDPSs
within the XYP subfamily originate from fungi. Two attempts
to express a fungal CDPS have been made in E. coli and were
unsuccessful (This study; Jacques et al., 2015). The identity of
their potential product(s), if any, remains to be determined in
a more appropriate assay. The four newly identified eukaryotic
CDPS sequences of the NYH subfamily originate from marine
species (coral, sea anemones or marine worms), like the already
characterized Nvec-CDPS2 (Seguin et al., 2011). The distribution
Frontiers in Microbiology | www.frontiersin.org 8 February 2018 | Volume 9 | Article 46
Gondry et al. Newly Characterized Cyclodipeptide Synthases
TABLE 3 | Specificity groups identified and their consensus motifs of P1 and P2
determined from characterized CDPSs.
Specificity
group (*)
Consensus motif for P1 Consensus motif for P2
cWW (NYH)
(9 / 22)
cLL (NYH)
(10 / 123)
cCC (NYH)
(11 / 60)
cAE (XYP)
(8 / 55)
cYY (NYH)
(6 / 145)
cFX (NYH)
(8 / 31)
cW2X (NYH)
(7 / 34)
cPX (NYH)
(5 / 9)
cLE (XYP)
(2 / 19)
cGE (XYP)
(1 / 7)
cAA (XYP)
(2 / 33)
cGG (XYP)
(1 / 17)
cLI/cLL (XYP)
(4 / 34)
cCX (NYH)
(12 / 61)
cW1X (NYH)
(12 / 36)
cXE (XYP)a
(9 / 81)
cAX (XYP)a
(10 / 88)
Specificity groups are named according to the main cyclodipeptide synthesized; the family
NYH or XYP of the CDPSs forming the group is indicated. The numbers in brackets (*)
correspond to the number of CDPSs experimentally characterized vs. the total number
of CDPSs in the group (Last up-date: June 2017). Groups for which less than five
CDPSs have been experimentally characterized are labeled in blue. Sequence motifs
correspond to residues suspected to delineate P1 and P2, determined for each CDPS (see
Supplemental Data Set 4 and Table S2). They are presented as logo, corresponding
to the frequency plot of amino acid at the different positions of P1 and P2 for characterized
enzymes of the specificity group (see also Table S2 for comparison with logos obtained
with enzymes of the whole specificity group). Degenerated positions are indicated in gray,
amino acids likely to be essential for specificity are indicated in red.
aThe consensus motif for cXE was obtained using cAE, cLE and cGE groups of CDPSs,
that for cAX was obtained using cAE and cAA groups.
FIGURE 3 | Predicted activities of the 765-CDPS set. The different specificities
predicted are colored using the same code as for the phylogenetic tree
(Figure 2). “Characterized” refers to enzymes experimentally characterized but
not belonging to a predictable group.
of phyla within NYH and XYP subfamilies is very different
(Figures 4C,D). Most NYHCDPSs originate from actinobacteria
(71.8%); Firmicutes (19.1%), with all CDPSs synthesizing or
predicted to synthesize mainly cLL; and Proteobacteria (8.5%).
Most NYH CDPSs are similar in length, but some enzymes are
fused to a second protein domain in the C-terminal part; putative
methyltransferase, P450 or ABC-transporter domains are found.
NYH CDPS 71 is thus part of a larger protein consisting of
two domains: an N-terminal CDPS moiety of approximately
240 amino acids fused to a 410 amino-acid C-terminal P450
domain. We found the isolated N-terminal domain to synthesize
significant quantities of cWY. This result suggests that CDPSs
can be functional within largermulti-domain proteins containing
tailoring domains. Most XYP CDPSs (Figure 4D) come from
proteobacteria (65.1%), followed by actinobacteria (16.7%). The
remaining 18% are distributed among eight different phyla. The
much larger diversity in sequence features observed in XYP
CDPSs relative to those of the NYH subfamily may be related
to this diverse phyla in which they are found. Indeed, some
XYP CDPSs contain large amino acid insertions or deletions
relative to the structurally characterized enzymes (Jacques et al.,
2015). These patterns are generally characteristic of particular
specificity subgroups. Thus, all CDPSs predicted to mainly
synthesize cAA originate from Legionellaceae and contain several
insertions and an additional C-terminal domain of unknown
function.
DISCUSSION
Many natural products are synthesized around a 2,5-
diketopiperazine core. They are of considerable interest
due to the great diversity of their biological activities associated
with the various chemical modifications that can occur occur on
the initial cyclodipeptide scaffold (Borthwick, 2012). Although
numerous DKPs have been identified in bacteria, most have
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FIGURE 4 | Phyla distribution of putative (A) and characterized (B) CDPSs and according to their belonging to NYH (C) or XYP (D) family.
been isolated and characterized from fungi of the Aspergillus and
Penicillium species. The number of characterized biosynthetic
pathways for DKPs is relatively low relative to their known
diversity (Belin et al., 2012; Giessen and Marahiel, 2015).
Ten pathways that involve NRPSs have been decoded (Belin
et al., 2012; Giessen and Marahiel, 2015), whereas only six
have been shown to depend on CDPSs: albonoursin (Lautru
et al., 2002), pulcherrimin (Cryle et al., 2010), mycocyclosin
(Belin et al., 2009), methylated ditryptophan (Giessen et al.,
2013a), nocazines (Giessen et al., 2013b), and, most recently
bicyclomycin (Meng et al., 2017; Patteson et al., 2017). In this
context, mapping the diversity of cyclodipeptides attainable by
CDPSs allows the identification of new gene clusters responsible
for the synthesis of DKPs with high pharmacological potential,
as illustrated by the recent identification of the biosynthetic
pathway of bicyclomycin, which involves a CDPS predicted
to belong to the cLI/cLL-synthesizing group (Patteson et al.,
2017).
CDPSs are often promiscuous enzymes. Our early works on
CDPSs led us to propose that CDPSs generally produce onemajor
cyclodipeptide and several minor cyclodipeptides according to
the general formula cyclo(AA1-X), in which AA1 is the preferred
amino acyl accommodated in P1 (i.e., the amino acyl common
to the most highly produced cyclodipeptides) and X is a variable
amino acyl accommodated in P2 (Moutiez et al., 2017). This
proposition was essentially based on results obtained for AlbC.
Indeed, its preferred amino acyl is phenylalanyl, which was
shown to be accommodated in P1 (Moutiez et al., 2014b). AlbC
produces mainly cFL, along with up to 12 other cyclodipeptides,
four of which contain phenylalanine and are produced in
significant quantities (Gondry et al., 2009). These pioneering
studies showed that the preferred amino acyl is accommodated
in P1 with high specificity and suggested lower specificity for
binding of the second aa-tRNA. However, characterization of the
CDPS of A. mirum, which exclusively synthesizes cWW suggests
that the binding of both aa-tRNAs can be stringent (Giessen
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et al., 2013a; Jacques et al., 2015). These results suggest that the
amino acid preferentially used by a CDPS can be accommodated
by either the P1 or P2 pockets. The CDPS from N. prasina was
characterized by Brockmeyer and Li (2017) during the writing of
this manuscript. According to our model, this enzyme belongs
to the cFX-synthesizing group (Supplemental Data Set 4). They
found that it synthesizes cFY as the main product (87%) in
agreement with our prediction, and minor tyrosyl-containing
cyclodipeptides, suggesting a strong determinant of specificity
toward the second substrate used by the enzyme. We observed
the same type of results for CDPS 66, which also produces
mainly cFY (94%) and cYY (6%). This clearly shows that
experimental data are needed to identify all cyclodipeptides that
can be synthesized by a yet-to-be-characterized CDPS and to
possibly deduce a preferred aminoacyl. This also confirms that
our predictive approach can only be used to determine the main
cyclodipeptide produced, and should not be used to infer the type
of cyclodipeptides made by a CDPS.
Analysis of the variability of binding-site residues within
a specificity-based group and between phylogenetically close
groups provides evidence for specificity-conferring key positions
in sequencemotifs of the pockets. Comparison of the P1 sequence
motif of CDPSs related to CDPS 87, which produces cGE, with
those found for the cLE- and cAE-synthesizing group appears
to confirm the predominant role of the second residue in the
recognition of the first amino acid used by these CDPSs. Previous
analyses suggested that the presence of alanine or leucine at this
position correlates with the synthesis of cLE or cAE, respectively
(Jacques et al., 2015). CDPS 87 has phenylalanine at this position.
Its size would prevent the binding of any side chain and favor
the presence of a glycyl residue. Such a pattern involving a
predominant key residue is also involved in the discrimination
between phenylalanyl and tyrosyl moieties in P1 for cFX- and
cYY- synthesizing NYH groups. Previous studies carried out
on AlbC and Rv2275 identified the presence of an asparagine
at position 8 of P1 (L200 in AlbC and N251 in Rv2275) to
be essential for the recognition of the tyrosyl (Vetting et al.,
2010; Sauguet et al., 2011). Among the newly characterized
enzymes, CDPS 67 has a P1 motif closely related to that of the
cYY-synthesizing group, with a valine instead of asparagine at
position 8 and was shown to produce mainly cFY. The cFX-
and cW2X-synthesizing groups present a further example. The
sequence motifs determined for P1 in both groups are very
similar (Table 2 and Table S1). The specific recognition of the
tryptophanyl to the detriment of phenylalanyl moiety appears to
be related to the presence of the couple (V/I)A at positions 3 and
4 of P1.
This study reveals that different pocket motifs can lead to the
preferential recognition of the same amino-acid residue. This
had already been noted for CDPSs with similar activities, but
belonging to the different subfamilies, NYH and XYP (Jacques
et al., 2015); this can be extended to enzymes within the same
subfamily. Thus, two different consensus sequences have been
identified for the binding of tryptophanyl in P1 pockets of
NYH CDPSs. Similarly, different P1 motifs recognize leucyl in
XYP CDPSs (e.g., previously characterized CDPS 21 synthesizing
cLL vs. cLE- or cLI/cLL synthesizing CDPSs). The specificity
code linking the composition of substrate binding pockets to
specificity appears to be degenerate and there are multiple
strategies to bind the same substrate as for NRPSs (Stachelhaus
et al., 1999).
Most of the newly predicted specificity-based groups belong
to the NYH subfamily and the prediction only concerns the
amino acid recognized by P1 for most. We failed to identify
a characteristic pattern for P2 associated with the recognition
of a specific residue, except for the XYP CDPSs synthesizing
cXE cyclodipeptides. Previous studies on AlbC indicated that
most of the recognition of the first substrate is centered on the
aminoacyl moiety of the aa-tRNA substrate, whereas recognition
of the second substrate involves both the aminoacyl and the
tRNA moieties (Moutiez et al., 2014b). The tRNA binding sites
are still unknown. Their identification, and particularly the
identification of the binding site for the tRNA moiety of the
second substrate, would be a decisive step toward improving
the predictive model for the second amino acid incorporated by
CDPSs. The results obtained for the three CDPSs (63, 64, and
70) that synthesize Trp-containing cyclodipeptides with cWW as
the main product are particularly indicative of the importance
of the tRNA sequence for the specific recognition of the
second substrates. The previously characterized group of cWW-
synthesizing enzymes exclusively produced this cyclodipeptide,
also showing strong specificity toward the second amino acid
(Giessen et al., 2013a; Jacques et al., 2015). Both CDPSs 63
and 10 can synthesize approximately 10 cyclodipeptides other
than cWW, some in significant quantities. The chemical and
physical features of the second incorporated amino acid are
surprisingly diverse, ranging from large hydrophobic residues,
such as Trp or Leu, to small ones, such as Ala or Pro, and
even polar ones, such as Ser or Glu/Gln. This suggests that
specificity determinants toward the amino acid moiety are
particularly weak. The identity of the N1-N72 base pair of
the tRNA moiety was found to be the major determinant of
specificity for the recognition of the second substrate by AlbC.
In the case of CDPSs 63 and 70, specific interactions between
tRNA bases and the CDPS probably occur at positions other
than the first base pair, as the composition of this pair largely
differs between tRNA moieties of all substrates used by these
enzymes.
The proportion of CDPSs with predictable activity is
significantly higher for those of the NYH than XYP subfamily.
It is important to keep in mind that all structural data concerning
the identification of P1 and P2 were obtained with NYH CDPSs.
Although the predictive model was relevant for several XYP
groups, we cannot exclude that the positions of the residues
lining the pockets are not strictly conserved between XYP and
NYH CDPSs, nor throughout each subfamily. Determination
of the tridimensional structures of XYP enzymes will probably
refine the definition of the two binding pockets. Parallels can be
drawn with the evolution of the predictive models of amino acid
recognition by adenylation domains of NRPSs. The first models
were based on the identification of amino acids lining the binding
pocket of the aminoacyl moiety (Stachelhaus et al., 1999; Challis
et al., 2000) and were further refined to include all active site
residues close to the substrate (Rausch et al., 2005). Such an
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approach makes it possible to account for potential differences
in the size and geometry of the active site. This is probably the
future of CDPS activity prediction, as structural knowledge on
CDPSs will continue to increase.
The second important aspect of this study is the expanded
number of identified cyclodipeptides synthesized by CDPSs
and, as a consequence, the expanded diversity of additional
complex DKPs potentially attainable through CDPS-dependent
pathways. Among the new cyclodipeptides identified, there
were many tryptophanyl-containing cyclodipeptides produced in
large quantities as the main products of several CDPSs. Until
now, cWWwas the only tryptophanyl-containing cyclodipeptide
known to be synthesized by CDPSs in significant amounts
(Seguin et al., 2011; Giessen et al., 2013a; Jacques et al., 2015).
Tryptophanyl-containing cyclodipeptides constitute the largest
source of precursors for DKPs with therapeutic potential (Li,
2010; Borthwick, 2012). The intrinsic chemical reactivity of the
tryptophan side chain makes it the center of a wide variety of
reactions. Thus, electrophilic substitution reactions can occur
at all positions of its indole ring and involve modifications as
varied as methylation, hydroxylation, nitration, and prenylation,
among others (Alkhalaf and Ryan, 2015). Of special interest
is the cyclo (L-Trp-L-Pro) or brevianamide F, that was found
to be the most prevalent precursor of valuable DKPs, such as
brevianamides, tryprostatins, norgeamides, and fumitremorgins
(Borthwick, 2012; Gu et al., 2013). The biosynthetic pathway
of brevianamide F was characterized in Aspergillus fumigatus
and shown to depend on an NRPS (Maiya et al., 2006). Both
CDPSs 74 (S. sp. NRRL S-1868) and 75 (S. sp. NRRL F-
5123) synthesize substantial amounts of cWP, demonstrating
that there is a bacterial CDPS-dependent alternative for the
synthesis of brevianamide F. The surrounding genes of these
CDPSs encode numerous putative tailoring enzymes, such
as cytochrome P450 and reductases/oxidases in the case of
CDPS 74 (NCBI entry NZ_JOGD01000018.1) and, among
others, several putative methyltransferases for CDPS 75 (NCBI
entry NZ_JOHY01000010.1). This suggests the existence of
larger gene clusters that may be responsible for the synthesis
of modified cyclo(L-Trp-L-Pro) in these Streptomyces species.
Their characterization may lead to the identification of new
pathways for already identified DKPs or the identification of new
derivatives.
Several newly characterized CDPSs produce other
tryptophanyl-containing cyclodipeptides that could also be
potential precursors of more complex DKPs. CDPSs 69 and
71 synthesize cWY, for which the scaffold can be identified
in some thaxtomin derivatives (King and Lawrence, 1996;
King and Calhoun, 2009; Borthwick, 2012; Giessen and
Marahiel, 2014). CDPS 68 synthesizes cWL, which is related
to cyclomarazines (Schultz et al., 2008). The already identified
biosynthetic pathways for these DKPs involveNRPSs. The CDPSs
characterized herein are all part of larger putative gene clusters
that include putative cytochrome P450, methyltransferases, and
other tailoring enzymes. The identification of CDPS-dependent
pathways for such molecules, i.e., small efficient biocatalysts
compared to NRPSs, may facilitate the development of new
synthetic pathways to produce novel active DKPs.
In conclusion, our work expands the first predictive model
that we proposed for the specificity of CDPSs (Jacques et al.,
2015). The identification of CDPS products constitutes the first
step toward the deciphering of CDPS-dependent pathways. The
identification of CDPS-synthesized cyclodipeptide precursors of
high-value DKPs makes CDPSs highly attractive as efficient
systems for biological synthetic approaches.
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